Orthofix International | OFIX - Ebitda


Orthofix International reported $27.88M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Accuray USD -685K 900K Sep/2024
AngioDynamics USD 5.94M 3.78M Sep/2025
Artivion USD 22.72M 1.84M Dec/2025
AtriCure USD 26.8M 480K Sep/2026
Dexcom USD 435.2M 46.5M Sep/2026
EDAP TMS EUR -6.47M 1.54M Mar/2026
Globus Medical USD 279.84M 48.01M Jun/2026
Insulet USD 233.7M 33.9M Sep/2026
Integra LifeSciences USD 79.79M 1.37M Sep/2026
J&J USD 8.99B 721M Jun/2026
Medtronic USD 2.63B 174M Jun/2026
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Orthofix International USD 27.88M 2.77M Dec/2025
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Smith & Nephew USD 796M 139M Dec/2025
STAAR Surgical USD 14.36M 5.64M Sep/2026
Stryker USD 1.83B 102M Sep/2026
Tandem Diabetes Care USD 6.42M 3.69M Jun/2026
Teleflex USD 122.91M 47.28M Jun/2026
Veracyte USD 41.24M 2.72M Sep/2026
Zimmer Biomet Holdings USD 634.8M 195.7M Sep/2026